Episode 7: How is Technology Reshaping the Medical Device Industry?

Featuring: Liv Williamsen is a medical device industry leader with nearly 20 years of experience, and has worked with a wide range of medical device companies from a Fortune 50 company to small start-ups. She has been responsible for building new markets in and outside of the US, leading sales & marketing teams, developing and running training programs for sales …

LTEN Focus Article: Driving the Evolution of Medical Affairs and MSLs

MSLs are under increasing pressure to provide complex scientific information to stakeholders. By Kristina BelyeaDirector of Content Marketing ACTO Over the past three years, there have been significant shifts and pivots in life sciences, including changes in how healthcare providers (HCPs)want to interact with pharmaceutical companies. This shift has made medical affairs and medical sciences liaisons (MSLs) increasingly crucial and …

Solutions – Med Affairs

Medical AffairsCL & DMedical AffairsCommercial ExcellenceITThe evolving needs inMedical Affairs Streamline Compliance Take advantage of proven learning pedagogies to fight the forgetting curve. Empower Remote Teams Give field teams access to learning sessions from anywhere, on any device Control and Manage Access Manage access with approved, up-to-date resources your field teams can use Trends in Medical Affairs0%of MSLs do not …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

ACTO Named One of the 2019 PM360 ELITE 100

TORONTO, May 21, 2019 /CNW/ – PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Parth Khanna, Kapil Kalra, and Kumar Erramilli as one of the 2019 PM360 ELITE 100 in the Entrepreneurs category. Now in its fifth year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. …

Our Story

Our storyHow did it all begin?Parth Khanna (Chief Executive Officer), Kapil Kalra (Chief Customer Officer), and Kumar Erramilli (Chief Technology Officer) met and were roommates as undergraduate students at the University of Waterloo. While they were each drawn to different academic studies, they shared a desire to make a positive impact on the world. After graduating, they each went their …

ACTO Recognized as “Life Sciences Commercial Analytics and AI Trailblazer” by Everest Group

Toronto, October 26, 2022: ACTO, the #1 learning platform in Life Sciences, has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence (AI) by Everest Group, a leading global research firm focused exclusively on strategic IT, business process, and engineering services. In its  “Start-ups Creating Buzz in the Life Sciences Commercial Technology” 2022 market report,  Everest Group …

LTEN Focus Article: The Global Impact of Learning in the Flow of Work

By Kristina BelyeaDirector of Content Marketing ACTO Supporting continuous learning puts companies leaps ahead of others Have you heard the phrase “learning in the flow of work?” Many industry leaders and companies are discussing how it is transforming the way commercial learning and development (CL&D) teams train and reskill employees. So, is this the next big thing to be adopted …

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

TORONTO, July 7, 2022 – ACTO, the omnichannel learning and enablement platform for life sciences, today announced the closing of a US$18 million equity financing. The investment was led by Questa Capital, a healthcare venture growth equity firm that actively invests in healthcare and life sciences software. With this investment, Questa joins ACTO’s existing investors: Resolve Growth Partners, Salesforce Ventures, Panache Ventures, and …